Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Millefiorini

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosisS Di Rezze, S Gupta, V Durastanti, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 1, 1991
Anterior corpus callosum atrophy and verbal fluency in multiple sclerosisC Pozzilli, S Bastianello, A Padovani, et al.
Chronobiology International|January 1, 1991
Circadian variation in the onset of acute cerebral ischemia: ethiopathogenetic correlates in 80 patients given angiographyD Toni, C Argentino, M Gentile, et al.
Rivista Di Neurologia|May 1, 1987
Evolution and severity markers in 233 MS patientsS Bernardi, C Buttinelli, M G Grasso, et al.
Acta Neurologica Scandinavica|November 1, 1995
Fatigue in MS is associated with specific clinical featuresC Colosimo, E Millefiorini, M G Grasso, et al.
Italian Journal of Neurological Sciences|December 1, 1990
24-month follow-up of multiple sclerosis patients treated with cyclophosphamideE Millefiorini, M Di Giovanni, S Bernardi, et al.
Arzneimittel-Forschung|March 1, 1991
Controlled clinical trials in strokeC Fieschi, M Frontoni, C Argentino, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 15, 2016
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosisL Rocchi, A Conte, M Bologna, et al.
Acta Neurologica Scandinavica|October 1, 1992
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalitiesE Millefiorini, A Padovani, C Pozzilli, et al.
Journal of Clinical Pharmacology|June 1, 1995
Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosisS De Castro, D Cartoni, E Millefiorini, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosisS Di Rezze, S Gupta, V Durastanti, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 1, 1991
Anterior corpus callosum atrophy and verbal fluency in multiple sclerosisC Pozzilli, S Bastianello, A Padovani, et al.
Chronobiology International|January 1, 1991
Circadian variation in the onset of acute cerebral ischemia: ethiopathogenetic correlates in 80 patients given angiographyD Toni, C Argentino, M Gentile, et al.
Rivista Di Neurologia|May 1, 1987
Evolution and severity markers in 233 MS patientsS Bernardi, C Buttinelli, M G Grasso, et al.
Acta Neurologica Scandinavica|November 1, 1995
Fatigue in MS is associated with specific clinical featuresC Colosimo, E Millefiorini, M G Grasso, et al.
Italian Journal of Neurological Sciences|December 1, 1990
24-month follow-up of multiple sclerosis patients treated with cyclophosphamideE Millefiorini, M Di Giovanni, S Bernardi, et al.
Arzneimittel-Forschung|March 1, 1991
Controlled clinical trials in strokeC Fieschi, M Frontoni, C Argentino, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 15, 2016
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosisL Rocchi, A Conte, M Bologna, et al.
Acta Neurologica Scandinavica|October 1, 1992
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalitiesE Millefiorini, A Padovani, C Pozzilli, et al.
Journal of Clinical Pharmacology|June 1, 1995
Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosisS De Castro, D Cartoni, E Millefiorini, et al.
Pageof 5